Cargando…
Moving beyond tight glucose control to safe effective glucose control
The impressive benefits related to the use of tight glucose control by intensive insulin therapy have not been reproduced until now in multicenter large-scale prospective randomized trials. Although the reasons for these failures are not entirely clear, we suggest the use of a stepwise approach – Sa...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2481442/ https://www.ncbi.nlm.nih.gov/pubmed/18495050 http://dx.doi.org/10.1186/cc6889 |
_version_ | 1782157992447180800 |
---|---|
author | Krinsley, James S Preiser, Jean-Charles |
author_facet | Krinsley, James S Preiser, Jean-Charles |
author_sort | Krinsley, James S |
collection | PubMed |
description | The impressive benefits related to the use of tight glucose control by intensive insulin therapy have not been reproduced until now in multicenter large-scale prospective randomized trials. Although the reasons for these failures are not entirely clear, we suggest the use of a stepwise approach – Safe, Effective Glucose Control – that will essentially target an intermediate blood glucose level. As compared with genuine tight glucose control, Safe, Effective Glucose Control – already used in many intensive care units worldwide – is intended to decrease the rate of hypoglycemia and the workload, while reducing the adverse effects of severe hyperglycemia. |
format | Text |
id | pubmed-2481442 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-24814422008-07-24 Moving beyond tight glucose control to safe effective glucose control Krinsley, James S Preiser, Jean-Charles Crit Care Commentary The impressive benefits related to the use of tight glucose control by intensive insulin therapy have not been reproduced until now in multicenter large-scale prospective randomized trials. Although the reasons for these failures are not entirely clear, we suggest the use of a stepwise approach – Safe, Effective Glucose Control – that will essentially target an intermediate blood glucose level. As compared with genuine tight glucose control, Safe, Effective Glucose Control – already used in many intensive care units worldwide – is intended to decrease the rate of hypoglycemia and the workload, while reducing the adverse effects of severe hyperglycemia. BioMed Central 2008 2008-05-16 /pmc/articles/PMC2481442/ /pubmed/18495050 http://dx.doi.org/10.1186/cc6889 Text en Copyright © 2008 BioMed Central Ltd |
spellingShingle | Commentary Krinsley, James S Preiser, Jean-Charles Moving beyond tight glucose control to safe effective glucose control |
title | Moving beyond tight glucose control to safe effective glucose control |
title_full | Moving beyond tight glucose control to safe effective glucose control |
title_fullStr | Moving beyond tight glucose control to safe effective glucose control |
title_full_unstemmed | Moving beyond tight glucose control to safe effective glucose control |
title_short | Moving beyond tight glucose control to safe effective glucose control |
title_sort | moving beyond tight glucose control to safe effective glucose control |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2481442/ https://www.ncbi.nlm.nih.gov/pubmed/18495050 http://dx.doi.org/10.1186/cc6889 |
work_keys_str_mv | AT krinsleyjamess movingbeyondtightglucosecontroltosafeeffectiveglucosecontrol AT preiserjeancharles movingbeyondtightglucosecontroltosafeeffectiveglucosecontrol |